Cellular, Molecular and Biomedical Reports (Jun 2024)

Structural carcinoma overall process: a systematic review

  • Ali Reza Arabestanino,
  • Seyed Sina Naghibi Irvani,
  • Arman Ai,
  • Bita Dinarvand

DOI
https://doi.org/10.55705/cmbr.2023.410370.1164
Journal volume & issue
Vol. 4, no. 2
pp. 88 – 99

Abstract

Read online

Abnormalities of several oncogenes and tumor suppressor genes have been identified in carcinomas during the last decade and of pathological warfare and physiological traits, and multiple genetic changes have been demonstrated in individual carcinomas. We conducted a systematic review of studies enrolling adolescents and adults with Carcinoma, every type in which a cancer intervention was randomized, or all study designs in which there was a primary or secondary outcome. We searched Ovid MEDLINE, EMBASE, and Evidence-Based Medicine Reviews from 1990 to June 2015. Two reviewers evaluated study eligibility and abstracted data. In total, 67 studies were included and consisted of 62 randomized trials, reviews, and 5 studies. None of the studies (0/81) provided a definition. Only one randomized trial provided a definition. We were unable to identify any definitions used in studies of adolescents and adults with Carcinoma. Given that a proportion of this population may receive intensive treatment, there is an urgent need for consensus-based definitions of use across trials and review systematic & and meta-analysis.

Keywords